Digital Health Screening in People With HIV in Uganda to Increase Alcohol Use Reporting: Qualitative Study on the Development and Testing of the Self-administered Digital Screener for Health.

HIV Uganda digital screening mobile phone unhealthy alcohol use

Journal

JMIR formative research
ISSN: 2561-326X
Titre abrégé: JMIR Form Res
Pays: Canada
ID NLM: 101726394

Informations de publication

Date de publication:
01 Sep 2022
Historique:
received: 16 11 2021
accepted: 21 07 2022
revised: 10 06 2022
entrez: 1 9 2022
pubmed: 2 9 2022
medline: 2 9 2022
Statut: epublish

Résumé

Alcohol consumption is a critical driver of the HIV epidemic worldwide, particularly in sub-Saharan Africa, where unhealthy alcohol use and HIV are prevalent. Brief alcohol interventions are effective in reducing alcohol use; however, they depend on effective screening for unhealthy alcohol use, which is often underreported. Thus, there is a need to develop methods to improve reporting of unhealthy alcohol use as an essential step toward referral to brief alcohol interventions. Self-administered digital health screeners may improve reporting. This study aimed to develop and test a digital, easy-to-use self-administered health screener. The health screener was designed to be implemented in a busy, underresourced HIV treatment setting and used by patients with varying levels of literacy. We conducted a qualitative study at the Immune Suppression Syndrome (ISS) Clinic of Mbarara Regional Referral Hospital in Uganda to develop and test a digital self-administered health screener. The health screener included a training module and assessed behaviors regarding general health, HIV care, and mental health as well as sensitive topics such as alcohol use and sexual health. We conducted focus group discussions with clinicians and patients with HIV of the Mbarara ISS Clinic who consumed alcohol to obtain input on the need for and content, format, and feasibility of the proposed screener. We iteratively revised a tablet-based screener with a subset of these participants, piloted the revised screener, and conducted individual semistructured in-depth interviews with 20 participants who had taken part in our previous studies on alcohol and HIV, including those who had previously underreported alcohol use and with low literacy. A total of 45 people (n=5, 11% clinicians and n=40, 89% Mbarara ISS Clinic patients) participated in the study. Of the patient participants, 65% (26/40) were male, 43% (17/40) had low literacy, and all (40/40, 100%) had self-reported alcohol use in previous studies. Clinicians and patients cited benefits such as time savings, easing of staff burden, mitigation of patient-provider tension around sensitive issues, and information communication, but also identified areas of training required, issues of security of the device, and confidentiality concerns. Patients also stated fear of forgetting how to use the tablet, making mistakes, and losing information as barriers to uptake. In pilot tests of the prototype, patients liked the feature of a recorded voice in the local language and found the screener easy to use, although many required additional help and training from the study staff to complete the screener. We found a self-administered digital health screener to be appealing to patients and clinicians and usable in a busy HIV clinic setting, albeit with concerns about confidentiality and training. Such a screener may be useful in improving reporting of unhealthy alcohol use for referral to interventions.

Sections du résumé

BACKGROUND BACKGROUND
Alcohol consumption is a critical driver of the HIV epidemic worldwide, particularly in sub-Saharan Africa, where unhealthy alcohol use and HIV are prevalent. Brief alcohol interventions are effective in reducing alcohol use; however, they depend on effective screening for unhealthy alcohol use, which is often underreported. Thus, there is a need to develop methods to improve reporting of unhealthy alcohol use as an essential step toward referral to brief alcohol interventions. Self-administered digital health screeners may improve reporting.
OBJECTIVE OBJECTIVE
This study aimed to develop and test a digital, easy-to-use self-administered health screener. The health screener was designed to be implemented in a busy, underresourced HIV treatment setting and used by patients with varying levels of literacy.
METHODS METHODS
We conducted a qualitative study at the Immune Suppression Syndrome (ISS) Clinic of Mbarara Regional Referral Hospital in Uganda to develop and test a digital self-administered health screener. The health screener included a training module and assessed behaviors regarding general health, HIV care, and mental health as well as sensitive topics such as alcohol use and sexual health. We conducted focus group discussions with clinicians and patients with HIV of the Mbarara ISS Clinic who consumed alcohol to obtain input on the need for and content, format, and feasibility of the proposed screener. We iteratively revised a tablet-based screener with a subset of these participants, piloted the revised screener, and conducted individual semistructured in-depth interviews with 20 participants who had taken part in our previous studies on alcohol and HIV, including those who had previously underreported alcohol use and with low literacy.
RESULTS RESULTS
A total of 45 people (n=5, 11% clinicians and n=40, 89% Mbarara ISS Clinic patients) participated in the study. Of the patient participants, 65% (26/40) were male, 43% (17/40) had low literacy, and all (40/40, 100%) had self-reported alcohol use in previous studies. Clinicians and patients cited benefits such as time savings, easing of staff burden, mitigation of patient-provider tension around sensitive issues, and information communication, but also identified areas of training required, issues of security of the device, and confidentiality concerns. Patients also stated fear of forgetting how to use the tablet, making mistakes, and losing information as barriers to uptake. In pilot tests of the prototype, patients liked the feature of a recorded voice in the local language and found the screener easy to use, although many required additional help and training from the study staff to complete the screener.
CONCLUSIONS CONCLUSIONS
We found a self-administered digital health screener to be appealing to patients and clinicians and usable in a busy HIV clinic setting, albeit with concerns about confidentiality and training. Such a screener may be useful in improving reporting of unhealthy alcohol use for referral to interventions.

Identifiants

pubmed: 36048519
pii: v6i9e35015
doi: 10.2196/35015
pmc: PMC9478818
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e35015

Subventions

Organisme : NIAAA NIH HHS
ID : K24 AA022586
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI027763
Pays : United States

Informations de copyright

©Nneka Emenyonu, Allen Kekibiina, Sarah Woolf-King, Catherine Kyampire, Robin Fatch, Carol Dawson-Rose, Winnie Muyindike, Judith Hahn. Originally published in JMIR Formative Research (https://formative.jmir.org), 01.09.2022.

Références

J Gen Intern Med. 2009 Feb;24(2):189-97
pubmed: 19031037
AIDS Care. 2017 Nov;29(11):1442-1447
pubmed: 28278568
Int J Epidemiol. 2010 Dec;39(6):1541-55
pubmed: 20630991
AIDS. 2014 Jan 2;28(1):115-20
pubmed: 23939234
AIDS Behav. 2015 Mar;19(3):412-21
pubmed: 25074735
Med Clin North Am. 2017 Jul;101(4):823-837
pubmed: 28577629
J Med Internet Res. 2014 Jun 02;16(6):e142
pubmed: 24892426
Alcohol Clin Exp Res. 2005 Jul;29(7):1190-7
pubmed: 16046874
Drug Alcohol Depend. 2018 Oct 1;191:78-85
pubmed: 30096637
PLoS One. 2014 Jan 23;9(1):e85646
pubmed: 24465631
Prev Med. 2008 Jul;47(1):17-26
pubmed: 18302970
Front Psychiatry. 2014 Sep 01;5:114
pubmed: 25225487
Arch Intern Med. 1998 Sep 14;158(16):1789-95
pubmed: 9738608
Int J Environ Res Public Health. 2013 May 21;10(5):2043-57
pubmed: 23698697
Addiction. 2016 Feb;111(2):272-9
pubmed: 26381193
AIDS Behav. 2010 Dec;14(6):1265-8
pubmed: 20697796
PLoS Med. 2017 Sep 12;14(9):e1002386
pubmed: 28898239
Arch Psychiatr Nurs. 2018 Dec;32(6):872-877
pubmed: 30454631
Arch Intern Med. 2008 Mar 10;168(5):530-6
pubmed: 18332300
Alcohol Clin Exp Res. 2016 Oct;40(10):2056-2072
pubmed: 27696523
Drug Alcohol Rev. 2009 Jan;28(1):31-9
pubmed: 19320673
J Stud Alcohol Drugs. 2010 Sep;71(5):734-8
pubmed: 20731979
JAMA. 2018 Nov 13;320(18):1948
pubmed: 30422194
BMC Med Inform Decis Mak. 2014 Apr 16;14:34
pubmed: 24739205
Alcohol Alcohol. 2018 Jan 01;53(1):121-128
pubmed: 29087434
J Med Internet Res. 2019 Dec 17;21(12):e14420
pubmed: 31845903
Prev Med. 2004 Nov;39(5):969-75
pubmed: 15475031
Drug Alcohol Depend. 2019 Dec 1;205:107651
pubmed: 31683243
Can Fam Physician. 2014 Nov;60(11):e527-34
pubmed: 25551137
Drug Alcohol Depend. 2018 Feb 1;183:253-260
pubmed: 29306817
Subst Abus. 2020;41(3):347-355
pubmed: 31364948
Glob Health Action. 2020 Dec 31;13(1):1814035
pubmed: 32892740
Alcohol Alcohol. 2003 Nov-Dec;38(6):626-8
pubmed: 14633653
Subst Abus. 2007;28(3):67-77
pubmed: 18077304
J Med Internet Res. 2015 Jul 09;17(7):e170
pubmed: 26159179
J Acquir Immune Defic Syndr. 2018 Apr 15;77(5):492-501
pubmed: 29303844
Addict Sci Clin Pract. 2019 Oct 15;14(1):39
pubmed: 31615549
Contemp Clin Trials. 2019 Sep;84:105833
pubmed: 31446142
Drug Alcohol Depend. 2019 Sep 1;202:39-49
pubmed: 31299552
J Addict Med. 2013 May-Jun;7(3):204-9
pubmed: 23609212
Subst Abuse Treat Prev Policy. 2020 Aug 24;15(1):63
pubmed: 32831129
Addiction. 2021 Jan;116(1):159-169
pubmed: 32415721
Alcohol Alcohol. 2014 Sep-Oct;49(5):520-4
pubmed: 24939855
Cochrane Database Syst Rev. 2018 Feb 24;2:CD004148
pubmed: 29476653
PLoS One. 2009 May 27;4(5):e5696
pubmed: 19479081
Glob Health Action. 2014 Apr 10;7:22942
pubmed: 24725363
Drug Alcohol Depend. 2016 Sep 01;166:85-92
pubmed: 27402551
Ann Fam Med. 2013 Sep-Oct;11(5):460-6
pubmed: 24019278
AIDS Behav. 2010 Dec;14(6):1340-6
pubmed: 20809380
J Int Assoc Physicians AIDS Care (Chic). 2010 Jul-Aug;9(4):218-26
pubmed: 20798401
Child Adolesc Psychiatr Clin N Am. 2016 Oct;25(4):579-601
pubmed: 27613340
Health Psychol. 2008 Sep;27(5):628-37
pubmed: 18823189
BMJ. 2013 Jan 09;346:e8706
pubmed: 23303892
J Acquir Immune Defic Syndr. 2012 Dec 1;61(4):e63-4
pubmed: 23138732
J Med Internet Res. 2012 Oct 31;14(5):e142
pubmed: 23113955
AIDS Behav. 2020 Jun;24(6):1727-1742
pubmed: 31673913
Epidemiology. 2011 Jan;22(1):132-3
pubmed: 21150364
Popul Health Metr. 2017 Feb 10;15(1):4
pubmed: 28183309
AIDS. 2007 Apr;21 Suppl 2:S49-58
pubmed: 17413264
Adolesc Med State Art Rev. 2014 Apr;25(1):126-56
pubmed: 25022191
J Acquir Immune Defic Syndr. 2009 Oct 1;52(2):180-202
pubmed: 19668086
Subst Abuse Treat Prev Policy. 2019 Nov 14;14(1):52
pubmed: 31727086
Global Health. 2014 Apr 03;10:22
pubmed: 24708844
Prev Sci. 2007 Jun;8(2):141-51
pubmed: 17265194
Alcohol Alcohol. 2014 Jan-Feb;49(1):66-78
pubmed: 24232177
BMC Public Health. 2018 Aug 6;18(1):982
pubmed: 30081868
J Gen Intern Med. 2019 Dec;34(12):2824-2832
pubmed: 31414355
Alcohol Res. 2014;36(1):63-79
pubmed: 26259001
Res Nurs Health. 2017 Aug;40(4):360-371
pubmed: 28431187
J Subst Abuse Treat. 2018 Mar;86:70-77
pubmed: 29415854
BMC Public Health. 2013 Jul 11;13:644
pubmed: 23844552
J Subst Abuse Treat. 2017 Aug;79:67-74
pubmed: 28673530
AIDS Behav. 2019 Nov;23(11):3078-3092
pubmed: 31444711
PLoS One. 2014 Dec 01;9(12):e113152
pubmed: 25436894
Alcohol Res. 2014;36(1):47-62
pubmed: 26259000
AIDS Behav. 2012 Nov;16(8):2101-18
pubmed: 22116638
Alcohol. 2018 Sep;71:65-73
pubmed: 30055405
J Midwifery Womens Health. 2015 Jul-Aug;60(4):401-9
pubmed: 26220766
AIDS Behav. 2019 Jun;23(6):1656-1667
pubmed: 30560484
AIDS Behav. 2013 Jan;17(1):307-18
pubmed: 23108721
AIDS Behav. 2017 Nov;21(11):3057-3067
pubmed: 27221743
Addict Sci Clin Pract. 2018 Apr 9;13(1):8
pubmed: 29628018
Sex Transm Dis. 2007 Nov;34(11):856-63
pubmed: 18049422
Br J Gen Pract. 2013 Sep;63(614):e620-6
pubmed: 23998842
Yearb Med Inform. 2010;:13-20
pubmed: 20938564

Auteurs

Nneka Emenyonu (N)

Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, United States.

Allen Kekibiina (A)

MUST Grants Office, Mbarara University of Science and Technology, Mbarara, Uganda.

Sarah Woolf-King (S)

Department of Psychology, Syracuse University, Syracuse, NY, United States.

Catherine Kyampire (C)

MUST Grants Office, Mbarara University of Science and Technology, Mbarara, Uganda.

Robin Fatch (R)

Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, United States.

Carol Dawson-Rose (C)

Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, United States.

Winnie Muyindike (W)

MUST Grants Office, Mbarara University of Science and Technology, Mbarara, Uganda.

Judith Hahn (J)

Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, United States.

Classifications MeSH